Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Policy
Medicaid’s Role in Health and the Health Care Landscape: Key Takeaways from LDI Researchers
Memo: Delivered to Staff of U.S. Senate Committee on Finance
Print:
In May 2025, a Research Memo featuring research conducted by LDI Executive Director Rachel M. Werner, MD, PhD and LDI Senior Fellows Eric T. Roberts, PhD, Atheendar Venkataramani, MD, PhD, Paula Chatterjee, MD, MPH, Norma Coe, PhD, Molly Candon, PhD, Emily F. Gregory, MD, MHS, Margaret Lowenstein, MD, MPhil, MSHP, and Aditi Vasan, MD, MSHP was presented to staff of the U.S. Senate Committee on Finance.
The memo contained research on various aspects of Medicaid such as work requirements, the long-term care workforce, pregnancy care, and coverage for children.
Views expressed by the researchers are their own and do not necessarily represent those of the University of Pennsylvania Health System (Penn Medicine) or the University of Pennsylvania.
More on Policy at LDI
Estimated Overdose Deaths Due to the One Big Beautiful Bill Act
Letter: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Health Impacts of SNAP Provisions in the One Big Beautiful Bill Act
Letter: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Impact of House Budget Reconciliation Bill on Insurance Coverage
Comment: Delivered to the Senate Committee on Health, Education, Labor, and Pensions
Projected Mortality Impacts of the Budget Reconciliation Bill
Letter: Response to Request for Technical Assistance
Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Memo: Supplement to Response to Request for Technical Assistance